Replimune Group, Inc. Chief Executive Officer Sushil Patel filed a Form 4 on November 18, 2026, disclosing the sale of 49,026 shares of common stock on November 16, 2026, to cover tax withholding obligations arising from the vesting of Restricted Stock Units.

Key Highlights

  • Reporting person: Sushil Patel, Chief Executive Officer and Director of Replimune Group, Inc. (NASDAQ:REPL)
  • Shares disposed: 49,026 shares of common stock sold on November 16, 2026, coded as transaction type "S"
  • Weighted average price: $21.6 per share, with individual transactions ranging from $21.59 to $21.60 per share
  • Purpose of sale: Shares sold to cover tax withholding obligations connected to RSU vesting, under an irrevocable "sell to cover" provision in the award agreements
  • Beneficial ownership following transaction: 659,125 shares of common stock held directly
  • Not a discretionary sale: According to the filing, the transaction "does not represent a discretionary sale by the Reporting Person"

RSU Vesting Triggers Mandatory Tax-Cover Sale for Replimune CEO

According to the filing, Sushil Patel, who serves as both Chief Executive Officer and a Director of Replimune Group, Inc. (NASDAQ:REPL), disposed of 49,026 shares of common stock on November 16, 2026. The filing identifies the transaction code as "S" and reports a weighted average sale price of $21.6 per share. Individual sales occurred at prices ranging from $21.59 to $21.60 per share across multiple transactions.

The filing states that the shares were sold "to cover tax withholding obligations in connection with the vesting of the Reporting Person's Restricted Stock Units." The transaction was made in accordance with an irrevocable "sell to cover" provision contained in the RSU award agreements and, as the filing notes, "does not represent a discretionary sale by the Reporting Person." Patel retains the ability to provide, upon request, a breakdown of the number of shares sold at each price within the stated range to the issuer, any security holder, or SEC staff.

Following the reported transaction, Patel directly holds 659,125 shares of Replimune Group common stock, according to the filing. The Form 4 was signed by Shawn Glidden as attorney-in-fact and filed on November 18, 2026.

What Was Disclosed

Replimune Group CEO Sushil Patel disclosed the sale of 49,026 common shares on November 16, 2026, at a weighted average price of $21.6, solely to satisfy tax withholding requirements tied to RSU vesting, leaving him with 659,125 directly held shares.